Screening expansion raises questions in Barrett's care
-
May 20
New data support less invasive screening tools and biomarker-driven surveillance as physicians weigh how broadly to screen for Barrett’s esophagus and esophageal cancer.
Browse By
Biliary Tract
Colon
Esophagus
Liver
Pancreas
Small Bowel
Stomach
The GI hospitalist: A practice-changing health care opportunity
-
April 23
-
by Vasili Kalas, MD, PhD
The model is reshaping inpatient care, despite slow national adoption.
Pancreatic cystic lesions: A case-based approach
-
April 17
-
by Ross C.D. Buerlein, MD , Himesh B. Zaver, MD , Vanessa M. Shami, MD
Dr. Vanessa Shami, along with Drs. Ross Buerlein and Himesh Zaver, describe characteristic cyst findings on cross-sectional and endoscopic sonographic imaging, fluid analysis results, and management.
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
The Latest
Thiopurine withdrawal may raise flare risk in UC, not Crohn's
-
by Doug Brunk
Nationwide Korean cohort study found higher rates of corticosteroid use and composite adverse outcomes after early thiopurine withdrawal in UC patients on anti-TNF therapy; no excess risk was seen in Crohn's.
Magnetic neuromodulation reduced fecal incontinence
-
by Julie Greenbaum
“If adopted widely, this could be a game changer in the management of FI patients and provide long-lasting relief, safely and inexpensively.”
Screening expansion raises questions in Barrett's care
-
by Doug Brunk
New data support less invasive screening tools and biomarker-driven surveillance as physicians weigh how broadly to screen for Barrett’s esophagus and esophageal cancer.
Risankizumab shows benefit after ustekinumab failure
-
by Doug Brunk
Selective interleukin-23 inhibition produced meaningful remission rates in heavily pretreated patients with Crohn’s disease.
Experts offer roadmap for IBS-like symptoms in IBD remission
-
by Olivia Anderson
New Rome Foundation/IOIBD guidance defines "IBD with IBS-like symptoms" and recommends mechanism-based care over reflexive therapy escalation.
